Transmedics Group Inc buy BiotechBee
Start price
29.04.24
/
70%
€88.94
Target price
31.05.26
€130.00
Performance (%)
-30.63%
End price
14.12.24
€61.70
Summary
This prediction ended on 14.12.24 with a price of €61.70. Massive losses of -30.63% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Transmedics Group Inc | -3.043% | -3.043% | 60.663% |
| iShares Core DAX® | 0.048% | 1.311% | 11.378% |
| iShares Nasdaq 100 | 1.601% | -0.902% | 7.287% |
| iShares Nikkei 225® | 3.057% | 12.947% | 33.767% |
| iShares S&P 500 | 0.820% | 0.703% | 4.930% |
According to BiotechBee what are the pros and cons of Transmedics Group Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Transmedics Group Inc diskutieren
Buy mit Kursziel 130,0